| atypical melanocytic hyperplasia | Proliferation of melanocytes showing nuclear atypicality, especially as scattered single cells high in the epidermis; interpreted by some pathologists as malignant melanoma in situ. (05 Mar 2000) |
|---|---|
| atypical mycobacteria | Species of mycobacteria other than M. Tuberculosis or M. Bovis that can cause disease in immunocompromised humans. (05 Mar 2000) |
| atypical mycobacterial infection | <microbiology> Infection with organisms from the Mycobacterium genus other than tuberculosis. Risk factors include immunocompromised patients and those with AIDS. Mycobacterium avium intracellulare is an example which frequently infects AIDS patients. Atypical mycobacterial infections can cause abscesses, septic arthritis and osteomyelitis. Treatment can be difficult due to the emergence of resistance to standard antitubercular antibiotics. (27 Sep 1997) |
| atypical nevi | <dermatology> Moles whose appearance is different than normal moles. They may be larger and have irregular borders. Their colour may not be uniform and they may be flat or raised above the skin surface. Any mole that appears irregular may be suspect for skin cancer. (16 Dec 1997) |
| atypical pneumonia | <chest medicine> This refers to a type of pneumonia that does not follow the typical signs and symptoms of pneumonia. A number of different viral and bacterial agents have been identified which can cause this form of respiratory infection. Examples include Chlamydia pneumonia, psittacosis, Mycoplasma, influenza A or B, adenovirus and Legionella. Antibiotics will be necessary in all but the mildest cases. Symptoms generally improve in less than 2 weeks. (27 Sep 1997) |
| atypical pseudocholinesterase | A genetic variant of cholinesterase that fails to catalyze the hydrolysis of succinylcholine. See: dibucaine number, fluoride number. (05 Mar 2000) |
| atypical trigeminal neuralgia | Periodic pain in any region of the face, teeth, tongue, and occasionally in the occipital or shoulder area, which lasts several minutes to several days but has no trigger point and lacks the paroxysmal character of tic douloureux. Synonym: atypical facial neuralgia. (05 Mar 2000) |
| atypical verrucous endocarditis | Verrucous endocarditis sometimes associated with disseminated lupus erythematosus. Synonym: atypical verrucous endocarditis, Libman-Sacks syndrome, nonbacterial verrucous endocarditis. (05 Mar 2000) |
| regressing atypical histiocytosis | A rare disease characterised clinically by multiple ulcerating cutaneous papules and nodules which show spontaneous regression; the skin is infiltrated by malignant-appearing histiocytes. (05 Mar 2000) |
| pneumonia, atypical interstitial, of cattle | A cattle disease of uncertain cause, probably an allergic reaction. (12 Dec 1998) |
| mycobacterium, atypical | So-called atypical species of the genus mycobacterium. They are also called tuberculoid bacilli, i.e.: m. Buruli (see m. Ulcerans), m. Chelonae, m. Duvalii, m. Flavescens, m. Fortuitum, m. Gilvum, m. Gordonae, m. Intracellulare (see mycobacterium avium complex), m. Kansasii (kansas), m. Marinum, m. Obuense, m. Scrofulaceum, m. Szulgai, m. Terrae, m. Ulcerans, m. Xenopi. (12 Dec 1998) |
| mycobacterium infections, atypical | Infections with so called atypical mycobacteria (tuberculoid bacilli): m. Kansasii (kansas), m. Marinum, m. Scrofulaceum, m. Flavescens, m. Gordonae, m. Obuense, m. Gilvum, m. Duvali, m. Szulgai, m. Intracellulare (see mycobacterium avium complex), m. Xenopi (littorale), m. Ulcerans, m. Buruli, m. Terrae, m. Fortuitum (minetti, giae), m. Chelonae. (12 Dec 1998) |
| primary atypical pneumonia | An acute systemic disease with involvement of the lungs, caused by Mycoplasma pneumoniae and marked by high fever, cough, relatively few physical signs, and scattered densities on X-rays; usually associated with development of cold agglutinins and antibodies to the bacteria. Synonym: atypical pneumonia, Eaton agent pneumonia, mycoplasmal pneumonia. (05 Mar 2000) |
| adrenergic blocking agent | A compound that selectively blocks or inhibits responses to sympathetic adrenergic nerve activity (sympatholytic agent) and to epinephrine, norepinephrine, and other adrenergic amines (adrenolytic agent); two distinct classes exist, alpha-and beta-adrenergic receptor blocking agent's. (05 Mar 2000) |
| adrenergic neuronal blocking agent | A drug that prevents the release of norepinephrine from sympathetic nerve terminals; it does not inhibit the responses of the adrenergic receptors to circulating epinephrine, norepinephrine, and other adrenergic amines. (05 Mar 2000) |